| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 234 | 2023 | 2647 | 18.730 |
Why?
|
| Cerebral Amyloid Angiopathy | 77 | 2023 | 859 | 5.870 |
Why?
|
| Hematoma | 40 | 2023 | 758 | 4.790 |
Why?
|
| Stroke | 115 | 2023 | 9981 | 4.210 |
Why?
|
| Brain Ischemia | 56 | 2022 | 3265 | 3.130 |
Why?
|
| Cerebral Angiography | 25 | 2021 | 1285 | 2.120 |
Why?
|
| Leukoaraiosis | 13 | 2022 | 120 | 2.110 |
Why?
|
| Warfarin | 25 | 2017 | 1496 | 2.030 |
Why?
|
| Anticoagulants | 34 | 2023 | 4599 | 1.790 |
Why?
|
| Genetic Predisposition to Disease | 60 | 2022 | 17446 | 1.650 |
Why?
|
| Genome-Wide Association Study | 71 | 2023 | 12261 | 1.590 |
Why?
|
| Intracranial Hemorrhages | 14 | 2023 | 855 | 1.500 |
Why?
|
| Polymorphism, Single Nucleotide | 66 | 2023 | 15519 | 1.410 |
Why?
|
| Caregivers | 16 | 2022 | 2094 | 1.350 |
Why?
|
| Siderosis | 9 | 2023 | 102 | 1.260 |
Why?
|
| Aged | 263 | 2023 | 163280 | 1.230 |
Why?
|
| Brain | 57 | 2023 | 26385 | 1.220 |
Why?
|
| Apolipoprotein E4 | 12 | 2020 | 668 | 1.200 |
Why?
|
| Resilience, Psychological | 10 | 2020 | 676 | 1.190 |
Why?
|
| Hypertension | 29 | 2023 | 8480 | 1.130 |
Why?
|
| Genetic Variation | 28 | 2023 | 6544 | 1.130 |
Why?
|
| Aged, 80 and over | 145 | 2021 | 57776 | 1.070 |
Why?
|
| Apolipoproteins E | 20 | 2019 | 1438 | 1.050 |
Why?
|
| Humans | 449 | 2023 | 744343 | 1.020 |
Why?
|
| Middle Aged | 239 | 2023 | 213383 | 1.010 |
Why?
|
| Tomography, X-Ray Computed | 56 | 2023 | 20129 | 1.000 |
Why?
|
| Male | 298 | 2023 | 350118 | 0.960 |
Why?
|
| Intensive Care Units | 19 | 2022 | 3679 | 0.940 |
Why?
|
| Leukoencephalopathies | 8 | 2022 | 238 | 0.900 |
Why?
|
| Female | 295 | 2023 | 380194 | 0.900 |
Why?
|
| Apolipoprotein E2 | 10 | 2019 | 127 | 0.870 |
Why?
|
| Cerebrovascular Disorders | 11 | 2020 | 1504 | 0.860 |
Why?
|
| Magnetic Resonance Imaging | 102 | 2023 | 35421 | 0.860 |
Why?
|
| Family | 7 | 2021 | 3147 | 0.840 |
Why?
|
| Recovery of Function | 15 | 2021 | 2925 | 0.760 |
Why?
|
| Collagen Type IV | 5 | 2017 | 140 | 0.760 |
Why?
|
| Brain Edema | 7 | 2020 | 617 | 0.760 |
Why?
|
| Cerebral Arteries | 8 | 2017 | 494 | 0.760 |
Why?
|
| Cerebellar Diseases | 3 | 2021 | 226 | 0.730 |
Why?
|
| Brain Injuries | 6 | 2021 | 2025 | 0.730 |
Why?
|
| Boxing | 1 | 2019 | 15 | 0.720 |
Why?
|
| Atrial Fibrillation | 20 | 2023 | 5034 | 0.720 |
Why?
|
| Depression | 20 | 2022 | 7766 | 0.710 |
Why?
|
| Arteriolosclerosis | 1 | 2019 | 21 | 0.710 |
Why?
|
| Blood Pressure | 18 | 2022 | 8554 | 0.710 |
Why?
|
| Head | 2 | 2022 | 880 | 0.700 |
Why?
|
| Critical Illness | 9 | 2021 | 2670 | 0.700 |
Why?
|
| Genotype | 46 | 2022 | 12951 | 0.700 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2022 | 3255 | 0.680 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 3 | 2011 | 105 | 0.670 |
Why?
|
| Brain Diseases | 5 | 2019 | 1563 | 0.650 |
Why?
|
| Hospitals, Rural | 1 | 2020 | 172 | 0.650 |
Why?
|
| Prospective Studies | 84 | 2023 | 53288 | 0.650 |
Why?
|
| Risk Factors | 105 | 2023 | 72290 | 0.640 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 499 | 0.630 |
Why?
|
| Cohort Studies | 78 | 2023 | 40561 | 0.630 |
Why?
|
| Genetic Association Studies | 13 | 2019 | 2703 | 0.620 |
Why?
|
| Platelet Aggregation Inhibitors | 9 | 2019 | 3068 | 0.620 |
Why?
|
| Cerebral Cortex | 15 | 2019 | 5708 | 0.610 |
Why?
|
| Hemosiderosis | 4 | 2020 | 71 | 0.600 |
Why?
|
| Gene Frequency | 13 | 2019 | 3588 | 0.600 |
Why?
|
| Stress Disorders, Post-Traumatic | 10 | 2023 | 4266 | 0.580 |
Why?
|
| Critical Care | 10 | 2019 | 2647 | 0.580 |
Why?
|
| Severity of Illness Index | 28 | 2021 | 15540 | 0.570 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2006 | 50 | 0.560 |
Why?
|
| Survivors | 9 | 2021 | 2291 | 0.530 |
Why?
|
| Hospital Mortality | 12 | 2020 | 5317 | 0.530 |
Why?
|
| Genetic Loci | 12 | 2021 | 2575 | 0.530 |
Why?
|
| Antihypertensive Agents | 7 | 2021 | 2046 | 0.520 |
Why?
|
| Alleles | 13 | 2018 | 6933 | 0.520 |
Why?
|
| Anticonvulsants | 3 | 2015 | 1916 | 0.510 |
Why?
|
| Subarachnoid Hemorrhage | 7 | 2021 | 1018 | 0.510 |
Why?
|
| Adaptation, Psychological | 10 | 2022 | 2576 | 0.510 |
Why?
|
| Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.510 |
Why?
|
| Urinary Tract Infections | 3 | 2018 | 788 | 0.500 |
Why?
|
| Recurrence | 21 | 2021 | 8340 | 0.500 |
Why?
|
| Lymphopenia | 1 | 2017 | 285 | 0.500 |
Why?
|
| Propylene Glycols | 1 | 2014 | 92 | 0.490 |
Why?
|
| Professional-Family Relations | 3 | 2021 | 482 | 0.480 |
Why?
|
| Cerebral Ventricles | 2 | 2019 | 544 | 0.480 |
Why?
|
| Disease Progression | 28 | 2023 | 13284 | 0.470 |
Why?
|
| Amyloid | 5 | 2022 | 795 | 0.470 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 2010 | 257 | 0.470 |
Why?
|
| Longitudinal Studies | 32 | 2023 | 13989 | 0.470 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2013 | 95 | 0.460 |
Why?
|
| Myocardial Infarction | 9 | 2023 | 11727 | 0.460 |
Why?
|
| Retrospective Studies | 71 | 2023 | 77449 | 0.450 |
Why?
|
| Microvessels | 3 | 2017 | 544 | 0.450 |
Why?
|
| Nerve Fibers, Myelinated | 6 | 2013 | 957 | 0.450 |
Why?
|
| Research | 1 | 2022 | 1999 | 0.450 |
Why?
|
| Imines | 1 | 2012 | 33 | 0.440 |
Why?
|
| Glasgow Coma Scale | 13 | 2021 | 570 | 0.440 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2023 | 967 | 0.440 |
Why?
|
| Cerebral Infarction | 7 | 2018 | 1011 | 0.430 |
Why?
|
| Multivariate Analysis | 24 | 2020 | 12245 | 0.420 |
Why?
|
| Case-Control Studies | 37 | 2022 | 21746 | 0.420 |
Why?
|
| Sphingosine | 1 | 2014 | 307 | 0.420 |
Why?
|
| Predictive Value of Tests | 31 | 2021 | 15076 | 0.420 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1588 | 0.420 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 2 | 2023 | 53 | 0.410 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 113 | 0.410 |
Why?
|
| Brain Infarction | 5 | 2021 | 299 | 0.410 |
Why?
|
| Receptors, Complement 3b | 1 | 2012 | 145 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2021 | 8949 | 0.400 |
Why?
|
| Decision Making | 4 | 2022 | 3887 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 535 | 0.390 |
Why?
|
| Anxiety | 7 | 2020 | 4297 | 0.390 |
Why?
|
| Nervous System Diseases | 5 | 2018 | 1622 | 0.390 |
Why?
|
| Epilepsy | 4 | 2023 | 3310 | 0.390 |
Why?
|
| CADASIL | 4 | 2016 | 84 | 0.390 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 413 | 0.380 |
Why?
|
| Risk | 18 | 2019 | 9687 | 0.380 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2017 | 1121 | 0.370 |
Why?
|
| Prognosis | 39 | 2023 | 29063 | 0.370 |
Why?
|
| Plasma | 6 | 2017 | 575 | 0.370 |
Why?
|
| Length of Stay | 7 | 2014 | 6309 | 0.370 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 662 | 0.360 |
Why?
|
| Lactones | 1 | 2012 | 329 | 0.360 |
Why?
|
| Hematoma, Subdural, Intracranial | 3 | 2017 | 33 | 0.360 |
Why?
|
| Principal Component Analysis | 4 | 2014 | 940 | 0.350 |
Why?
|
| Cerebral Arterial Diseases | 3 | 2019 | 82 | 0.350 |
Why?
|
| Cognition Disorders | 15 | 2017 | 4043 | 0.350 |
Why?
|
| Adult | 82 | 2023 | 214055 | 0.350 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2016 | 245 | 0.350 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 643 | 0.340 |
Why?
|
| Pneumonia | 3 | 2018 | 2133 | 0.340 |
Why?
|
| Alzheimer Disease | 16 | 2023 | 8037 | 0.330 |
Why?
|
| Mutation | 7 | 2023 | 29786 | 0.320 |
Why?
|
| Migraine without Aura | 2 | 2022 | 83 | 0.320 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2022 | 2737 | 0.320 |
Why?
|
| Genetic Testing | 4 | 2019 | 3444 | 0.320 |
Why?
|
| Atrophy | 4 | 2020 | 1583 | 0.310 |
Why?
|
| Glutamic Acid | 1 | 2013 | 1169 | 0.310 |
Why?
|
| Vitamin K | 6 | 2017 | 295 | 0.310 |
Why?
|
| Blood Coagulation | 5 | 2019 | 1127 | 0.310 |
Why?
|
| Factor VIIa | 3 | 2007 | 101 | 0.310 |
Why?
|
| Brain Concussion | 5 | 2023 | 1320 | 0.300 |
Why?
|
| Genetics, Population | 2 | 2010 | 934 | 0.300 |
Why?
|
| Erythrocyte Transfusion | 2 | 2013 | 565 | 0.300 |
Why?
|
| International Normalized Ratio | 6 | 2017 | 367 | 0.290 |
Why?
|
| Migraine with Aura | 2 | 2022 | 203 | 0.290 |
Why?
|
| Logistic Models | 22 | 2021 | 13408 | 0.290 |
Why?
|
| Thromboembolism | 3 | 2019 | 986 | 0.290 |
Why?
|
| Comorbidity | 12 | 2020 | 10388 | 0.280 |
Why?
|
| Aspirin | 5 | 2014 | 3282 | 0.280 |
Why?
|
| Sepsis | 2 | 2018 | 2593 | 0.280 |
Why?
|
| Risk Assessment | 24 | 2023 | 23338 | 0.270 |
Why?
|
| Sex Factors | 12 | 2021 | 10397 | 0.270 |
Why?
|
| Statistics, Nonparametric | 9 | 2017 | 2886 | 0.270 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1442 | 0.270 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 996 | 0.270 |
Why?
|
| Odds Ratio | 19 | 2021 | 9849 | 0.270 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 2 | 2017 | 20 | 0.270 |
Why?
|
| Connexin 43 | 2 | 2018 | 207 | 0.260 |
Why?
|
| Single-Blind Method | 3 | 2020 | 1590 | 0.260 |
Why?
|
| Amyloid beta-Peptides | 8 | 2023 | 3587 | 0.260 |
Why?
|
| Europe | 10 | 2022 | 3339 | 0.260 |
Why?
|
| Intracranial Embolism | 3 | 2018 | 202 | 0.260 |
Why?
|
| Disability Evaluation | 4 | 2021 | 1827 | 0.260 |
Why?
|
| Nursing Staff, Hospital | 2 | 2019 | 346 | 0.250 |
Why?
|
| DNA, Mitochondrial | 1 | 2010 | 817 | 0.250 |
Why?
|
| Linkage Disequilibrium | 6 | 2020 | 1997 | 0.250 |
Why?
|
| Ticlopidine | 1 | 2010 | 899 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3158 | 0.250 |
Why?
|
| Neurology | 2 | 2019 | 763 | 0.250 |
Why?
|
| Treatment Outcome | 34 | 2021 | 63114 | 0.250 |
Why?
|
| Follow-Up Studies | 26 | 2021 | 39050 | 0.240 |
Why?
|
| Blood Pressure Determination | 3 | 2017 | 634 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2018 | 437 | 0.240 |
Why?
|
| Phenotype | 17 | 2021 | 16365 | 0.240 |
Why?
|
| Blood Coagulation Factors | 3 | 2015 | 355 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2020 | 793 | 0.230 |
Why?
|
| Acute Disease | 8 | 2020 | 7149 | 0.230 |
Why?
|
| Antifibrinolytic Agents | 4 | 2017 | 254 | 0.230 |
Why?
|
| Decision Support Techniques | 4 | 2009 | 1956 | 0.230 |
Why?
|
| Nicardipine | 2 | 2021 | 60 | 0.230 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2016 | 138 | 0.230 |
Why?
|
| Data Collection | 6 | 2021 | 3341 | 0.230 |
Why?
|
| Time Factors | 17 | 2021 | 40075 | 0.220 |
Why?
|
| Semaphorins | 1 | 2023 | 101 | 0.220 |
Why?
|
| Anemia | 2 | 2011 | 1506 | 0.220 |
Why?
|
| Epistasis, Genetic | 1 | 2005 | 365 | 0.220 |
Why?
|
| Chemokine CXCL10 | 1 | 2023 | 304 | 0.220 |
Why?
|
| Quality of Life | 8 | 2023 | 12804 | 0.220 |
Why?
|
| Embolism | 2 | 2017 | 408 | 0.220 |
Why?
|
| Hong Kong | 2 | 2021 | 148 | 0.210 |
Why?
|
| Models, Economic | 1 | 2006 | 713 | 0.210 |
Why?
|
| Proteins | 2 | 2015 | 6103 | 0.210 |
Why?
|
| Quantitative Trait Loci | 7 | 2018 | 2019 | 0.210 |
Why?
|
| Hypotension | 2 | 2018 | 884 | 0.200 |
Why?
|
| Thalamus | 2 | 2021 | 1023 | 0.200 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4149 | 0.200 |
Why?
|
| Oxidative Phosphorylation | 2 | 2014 | 481 | 0.190 |
Why?
|
| Mannose-Binding Lectin | 1 | 2022 | 150 | 0.190 |
Why?
|
| Pyridines | 1 | 2012 | 2825 | 0.190 |
Why?
|
| Family Relations | 2 | 2019 | 321 | 0.190 |
Why?
|
| Gene Dosage | 2 | 2019 | 1252 | 0.190 |
Why?
|
| Aniline Compounds | 5 | 2022 | 986 | 0.180 |
Why?
|
| Intracranial Pressure | 3 | 2010 | 326 | 0.180 |
Why?
|
| Electroencephalography | 5 | 2023 | 6150 | 0.180 |
Why?
|
| Fibrinolytic Agents | 5 | 2023 | 2158 | 0.180 |
Why?
|
| Calcium | 3 | 2019 | 5756 | 0.180 |
Why?
|
| Homocysteine | 4 | 2015 | 647 | 0.180 |
Why?
|
| Communication | 1 | 2014 | 3749 | 0.180 |
Why?
|
| Memory | 4 | 2017 | 2174 | 0.180 |
Why?
|
| Patient Transfer | 2 | 2019 | 761 | 0.170 |
Why?
|
| Stress, Psychological | 3 | 2020 | 4245 | 0.170 |
Why?
|
| Incidental Findings | 1 | 2004 | 689 | 0.170 |
Why?
|
| Patient Discharge | 7 | 2021 | 3313 | 0.170 |
Why?
|
| Sleep | 4 | 2023 | 4623 | 0.170 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 18 | 0.170 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 214 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2005 | 1301 | 0.170 |
Why?
|
| Age Factors | 8 | 2019 | 18370 | 0.170 |
Why?
|
| Brain Waves | 1 | 2023 | 401 | 0.170 |
Why?
|
| Hemorrhage | 4 | 2009 | 3461 | 0.170 |
Why?
|
| Cognition | 5 | 2023 | 6770 | 0.170 |
Why?
|
| Aphasia | 1 | 2020 | 179 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2016 | 168 | 0.160 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3445 | 0.160 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2019 | 114 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4371 | 0.160 |
Why?
|
| Radiography | 7 | 2014 | 7023 | 0.160 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 219 | 0.160 |
Why?
|
| Models, Genetic | 5 | 2018 | 3494 | 0.160 |
Why?
|
| Markov Chains | 4 | 2009 | 969 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2010 | 374 | 0.160 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 34 | 0.150 |
Why?
|
| Phenformin | 1 | 1997 | 16 | 0.150 |
Why?
|
| Patient Admission | 4 | 2019 | 1380 | 0.150 |
Why?
|
| Prevalence | 13 | 2023 | 15226 | 0.150 |
Why?
|
| Survival Analysis | 7 | 2023 | 10252 | 0.150 |
Why?
|
| Trauma, Nervous System | 1 | 2017 | 36 | 0.150 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 40 | 0.150 |
Why?
|
| Neurosciences | 2 | 2019 | 348 | 0.150 |
Why?
|
| Amyloidosis | 2 | 2022 | 795 | 0.150 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2017 | 22 | 0.150 |
Why?
|
| Subarachnoid Space | 1 | 2017 | 79 | 0.150 |
Why?
|
| Object Attachment | 1 | 2020 | 313 | 0.150 |
Why?
|
| Reproducibility of Results | 17 | 2018 | 19905 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 2 | 2014 | 935 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 4042 | 0.140 |
Why?
|
| Factor VIII | 1 | 2019 | 347 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2006 | 20 | 0.140 |
Why?
|
| Genome, Human | 4 | 2014 | 4420 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2006 | 42 | 0.140 |
Why?
|
| Age of Onset | 4 | 2017 | 3271 | 0.140 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 87 | 0.140 |
Why?
|
| Incidence | 9 | 2022 | 20947 | 0.140 |
Why?
|
| Factor VII | 2 | 2007 | 139 | 0.140 |
Why?
|
| Pastoral Care | 1 | 2017 | 73 | 0.140 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2016 | 110 | 0.130 |
Why?
|
| Brain Stem | 1 | 2021 | 846 | 0.130 |
Why?
|
| Acidosis, Lactic | 1 | 1997 | 142 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2016 | 284 | 0.130 |
Why?
|
| Hypernatremia | 1 | 2016 | 82 | 0.130 |
Why?
|
| Aftercare | 2 | 2021 | 866 | 0.130 |
Why?
|
| Survival Rate | 7 | 2021 | 12788 | 0.130 |
Why?
|
| Craniotomy | 1 | 2020 | 729 | 0.130 |
Why?
|
| United States | 19 | 2023 | 69872 | 0.130 |
Why?
|
| Magnesium | 1 | 2019 | 813 | 0.130 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 114 | 0.130 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 6487 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 882 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2017 | 354 | 0.130 |
Why?
|
| Electrocardiography | 4 | 2018 | 6442 | 0.130 |
Why?
|
| Hypocalcemia | 1 | 2016 | 191 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2020 | 1261 | 0.130 |
Why?
|
| Urine | 1 | 2017 | 370 | 0.130 |
Why?
|
| Pons | 1 | 2016 | 245 | 0.130 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 789 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2020 | 12720 | 0.130 |
Why?
|
| Registries | 4 | 2019 | 8089 | 0.130 |
Why?
|
| Neuroradiography | 1 | 2015 | 70 | 0.130 |
Why?
|
| Interpersonal Relations | 2 | 2020 | 1425 | 0.130 |
Why?
|
| Genetic Markers | 4 | 2022 | 2634 | 0.130 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 669 | 0.130 |
Why?
|
| Leukocytosis | 1 | 2016 | 247 | 0.130 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2015 | 102 | 0.120 |
Why?
|
| Thiazoles | 4 | 2013 | 1483 | 0.120 |
Why?
|
| Sputum | 1 | 2017 | 476 | 0.120 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 49 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2017 | 585 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2014 | 3327 | 0.120 |
Why?
|
| Metagenomics | 1 | 2018 | 428 | 0.120 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 605 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2021 | 8324 | 0.120 |
Why?
|
| Blood | 1 | 2017 | 598 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2022 | 1058 | 0.120 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2356 | 0.120 |
Why?
|
| Peroxidase | 1 | 2017 | 611 | 0.120 |
Why?
|
| Verbal Learning | 1 | 2016 | 467 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 475 | 0.120 |
Why?
|
| Causality | 4 | 2010 | 1275 | 0.120 |
Why?
|
| Genomics | 4 | 2023 | 5720 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3200 | 0.120 |
Why?
|
| Serum Albumin | 1 | 2017 | 676 | 0.120 |
Why?
|
| Proportional Hazards Models | 11 | 2017 | 12354 | 0.120 |
Why?
|
| Sex Characteristics | 3 | 2023 | 2585 | 0.120 |
Why?
|
| Sensitivity and Specificity | 11 | 2021 | 14722 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2020 | 748 | 0.120 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 8863 | 0.110 |
Why?
|
| Judgment | 1 | 2015 | 281 | 0.110 |
Why?
|
| Clinical Trials as Topic | 4 | 2017 | 7913 | 0.110 |
Why?
|
| Dementia | 2 | 2019 | 2518 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 5 | 2020 | 2731 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 295 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 603 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2022 | 2309 | 0.110 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4644 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2018 | 453 | 0.110 |
Why?
|
| Linear Models | 7 | 2019 | 5952 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 432 | 0.110 |
Why?
|
| Ischemia | 2 | 2019 | 1907 | 0.110 |
Why?
|
| Physicians | 1 | 2011 | 4567 | 0.110 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 140 | 0.110 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2013 | 60 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 462 | 0.110 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 2418 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1405 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1047 | 0.110 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2014 | 214 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 611 | 0.110 |
Why?
|
| Databases, Nucleic Acid | 1 | 2013 | 211 | 0.110 |
Why?
|
| Triglycerides | 2 | 2020 | 2454 | 0.110 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2013 | 122 | 0.100 |
Why?
|
| Glasgow Outcome Scale | 3 | 2021 | 109 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2014 | 3023 | 0.100 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 422 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2014 | 571 | 0.100 |
Why?
|
| Cyclonic Storms | 1 | 2013 | 119 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 471 | 0.100 |
Why?
|
| Family Health | 1 | 2017 | 1282 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 658 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 380 | 0.100 |
Why?
|
| Tidal Volume | 1 | 2013 | 490 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2017 | 7729 | 0.100 |
Why?
|
| Secondary Prevention | 2 | 2015 | 1530 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 322 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 6538 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
| Adolescent | 17 | 2022 | 85781 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1791 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2014 | 525 | 0.090 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 61 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.090 |
Why?
|
| Young Adult | 14 | 2020 | 56430 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 4 | 2015 | 2716 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2013 | 546 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2013 | 367 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2015 | 739 | 0.090 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 6993 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2012 | 280 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2017 | 1184 | 0.090 |
Why?
|
| Uric Acid | 1 | 2016 | 766 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 694 | 0.090 |
Why?
|
| Seizures | 3 | 2023 | 2859 | 0.090 |
Why?
|
| Hematocrit | 1 | 2011 | 636 | 0.090 |
Why?
|
| Autopsy | 2 | 2012 | 1020 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 9959 | 0.090 |
Why?
|
| Regression Analysis | 6 | 2017 | 6459 | 0.090 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2010 | 136 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1239 | 0.090 |
Why?
|
| Biomedical Technology | 1 | 2012 | 220 | 0.090 |
Why?
|
| Mental Health | 1 | 2023 | 3019 | 0.090 |
Why?
|
| Ear Canal | 1 | 2010 | 146 | 0.090 |
Why?
|
| Population Groups | 1 | 2010 | 209 | 0.080 |
Why?
|
| Positive-Pressure Respiration | 1 | 2013 | 633 | 0.080 |
Why?
|
| Cross-Sectional Studies | 11 | 2021 | 25043 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2569 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 441 | 0.080 |
Why?
|
| Posterior Cerebral Artery | 1 | 2008 | 24 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2012 | 2971 | 0.080 |
Why?
|
| Genes | 1 | 2013 | 1893 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1504 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2002 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1422 | 0.080 |
Why?
|
| Hematoma, Subdural | 1 | 2009 | 126 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 950 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2014 | 4740 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1499 | 0.080 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 272 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2009 | 1683 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 5853 | 0.070 |
Why?
|
| Disasters | 1 | 2013 | 511 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 1005 | 0.070 |
Why?
|
| Women's Health | 1 | 2017 | 2034 | 0.070 |
Why?
|
| Perception | 1 | 2014 | 1198 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 4328 | 0.070 |
Why?
|
| Positron-Emission Tomography | 5 | 2022 | 6234 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 728 | 0.070 |
Why?
|
| Emergency Service, Hospital | 5 | 2019 | 7659 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2917 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1184 | 0.070 |
Why?
|
| Neural Pathways | 2 | 2014 | 2972 | 0.070 |
Why?
|
| Haplotypes | 3 | 2010 | 2779 | 0.070 |
Why?
|
| Neocortex | 1 | 2010 | 400 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
| Taurine | 1 | 2006 | 94 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 3 | 2019 | 1344 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2006 | 111 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4091 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2008 | 305 | 0.070 |
Why?
|
| Hospitalization | 4 | 2022 | 10262 | 0.070 |
Why?
|
| Posture | 1 | 2010 | 958 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2005 | 151 | 0.070 |
Why?
|
| Fatigue | 2 | 2023 | 1531 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 4186 | 0.060 |
Why?
|
| Aging | 4 | 2011 | 8664 | 0.060 |
Why?
|
| Organ Size | 3 | 2020 | 2252 | 0.060 |
Why?
|
| Myocardium | 1 | 2018 | 4776 | 0.060 |
Why?
|
| Observer Variation | 3 | 2019 | 2593 | 0.060 |
Why?
|
| Models, Neurological | 3 | 2022 | 1774 | 0.060 |
Why?
|
| Life Change Events | 2 | 2023 | 938 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 2872 | 0.060 |
Why?
|
| Neoplasms | 3 | 2019 | 21683 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1861 | 0.060 |
Why?
|
| Hemosiderin | 1 | 2004 | 43 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2421 | 0.060 |
Why?
|
| Research Design | 2 | 2012 | 5987 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2022 | 3913 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2459 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9146 | 0.060 |
Why?
|
| Exons | 1 | 2010 | 2437 | 0.060 |
Why?
|
| Hospitals | 3 | 2021 | 3952 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 370 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7186 | 0.060 |
Why?
|
| Valine | 2 | 2016 | 413 | 0.060 |
Why?
|
| Self Efficacy | 2 | 2020 | 616 | 0.060 |
Why?
|
| Nerve Net | 1 | 2016 | 2174 | 0.060 |
Why?
|
| Child Abuse | 1 | 2013 | 1030 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2017 | 2305 | 0.060 |
Why?
|
| Multifactorial Inheritance | 2 | 2022 | 1194 | 0.060 |
Why?
|
| International Cooperation | 1 | 2010 | 1420 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1248 | 0.060 |
Why?
|
| Genetic Counseling | 1 | 2007 | 600 | 0.060 |
Why?
|
| Methionine | 2 | 2016 | 590 | 0.060 |
Why?
|
| Internet | 2 | 2013 | 3064 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3086 | 0.060 |
Why?
|
| Neutrophils | 1 | 2016 | 3719 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 1738 | 0.060 |
Why?
|
| Central Nervous System Infections | 1 | 2004 | 56 | 0.060 |
Why?
|
| Basilar Artery | 2 | 2019 | 200 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3752 | 0.060 |
Why?
|
| Geriatric Psychiatry | 1 | 2023 | 70 | 0.060 |
Why?
|
| Vasculitis | 1 | 2007 | 519 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13815 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9313 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2002 | 63 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 604 | 0.050 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 2148 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 4456 | 0.050 |
Why?
|
| Palliative Care | 1 | 2017 | 3493 | 0.050 |
Why?
|
| Kentucky | 1 | 2002 | 83 | 0.050 |
Why?
|
| Clusterin | 1 | 2022 | 72 | 0.050 |
Why?
|
| Patient Selection | 2 | 2019 | 4215 | 0.050 |
Why?
|
| Algorithms | 5 | 2019 | 13881 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3462 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 124 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1184 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2020 | 1814 | 0.050 |
Why?
|
| Corpus Callosum | 2 | 2022 | 737 | 0.050 |
Why?
|
| American Heart Association | 2 | 2017 | 1056 | 0.050 |
Why?
|
| Ohio | 1 | 2002 | 337 | 0.050 |
Why?
|
| Child Development | 1 | 2013 | 2223 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 152 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 426 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3251 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 2161 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2016 | 6077 | 0.050 |
Why?
|
| Problem Solving | 1 | 2023 | 440 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2023 | 445 | 0.050 |
Why?
|
| Embolism, Cholesterol | 1 | 2000 | 34 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2006 | 5097 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2004 | 981 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2005 | 914 | 0.050 |
Why?
|
| Africa | 1 | 2022 | 673 | 0.050 |
Why?
|
| RNA | 1 | 2010 | 2749 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2022 | 1859 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2022 | 2838 | 0.040 |
Why?
|
| Diagnosis, Differential | 5 | 2016 | 12959 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1639 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 12745 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2916 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3508 | 0.040 |
Why?
|
| Child | 9 | 2023 | 77709 | 0.040 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 97 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 10638 | 0.040 |
Why?
|
| ROC Curve | 2 | 2021 | 3527 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2020 | 165 | 0.040 |
Why?
|
| Persistent Vegetative State | 1 | 2021 | 260 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2004 | 859 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2021 | 238 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3920 | 0.040 |
Why?
|
| Vertebral Artery | 1 | 2019 | 192 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2020 | 517 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 639 | 0.040 |
Why?
|
| Polyneuropathies | 1 | 2019 | 137 | 0.040 |
Why?
|
| Brain Mapping | 4 | 2021 | 6669 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6600 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2018 | 1783 | 0.040 |
Why?
|
| Pamphlets | 1 | 2018 | 75 | 0.040 |
Why?
|
| Sleep Stages | 1 | 2022 | 686 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 684 | 0.040 |
Why?
|
| Emotions | 2 | 2022 | 2661 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2421 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1170 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2019 | 329 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2009 | 5391 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 2645 | 0.040 |
Why?
|
| Spouses | 1 | 2020 | 286 | 0.040 |
Why?
|
| Contrast Media | 2 | 2009 | 5300 | 0.040 |
Why?
|
| Anisotropy | 2 | 2014 | 1265 | 0.040 |
Why?
|
| Mortality | 2 | 2020 | 2864 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6038 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2021 | 599 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 402 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2019 | 457 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2019 | 502 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 2019 | 413 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 143 | 0.040 |
Why?
|
| Antiporters | 1 | 2018 | 277 | 0.040 |
Why?
|
| Arteries | 2 | 2014 | 1119 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 1972 | 0.040 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 315 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 356 | 0.030 |
Why?
|
| Occipital Lobe | 2 | 2008 | 379 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2005 | 1207 | 0.030 |
Why?
|
| Sports | 1 | 2022 | 688 | 0.030 |
Why?
|
| Violence | 1 | 2022 | 909 | 0.030 |
Why?
|
| Electronic Health Records | 2 | 2023 | 4468 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9583 | 0.030 |
Why?
|
| Edema | 1 | 2020 | 789 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7799 | 0.030 |
Why?
|
| Proteomics | 2 | 2023 | 3638 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2021 | 2297 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2004 | 1373 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8663 | 0.030 |
Why?
|
| Polysomnography | 1 | 2022 | 1776 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.030 |
Why?
|
| Haiti | 1 | 1997 | 553 | 0.030 |
Why?
|
| Reference Values | 2 | 2019 | 4982 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2019 | 556 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 544 | 0.030 |
Why?
|
| Iodine | 1 | 2017 | 286 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2017 | 356 | 0.030 |
Why?
|
| Longevity | 1 | 2023 | 1070 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2018 | 810 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 386 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 642 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 794 | 0.030 |
Why?
|
| Software | 3 | 2017 | 4443 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2019 | 444 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 667 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3521 | 0.030 |
Why?
|
| New Orleans | 1 | 2013 | 27 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2014 | 100 | 0.030 |
Why?
|
| Anger | 1 | 2016 | 402 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6365 | 0.030 |
Why?
|
| Population | 1 | 2014 | 142 | 0.030 |
Why?
|
| RGS Proteins | 1 | 2013 | 77 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 2013 | 66 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2072 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2013 | 87 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2014 | 23403 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1188 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2018 | 890 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2018 | 921 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9438 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2013 | 195 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1850 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2170 | 0.030 |
Why?
|
| Entorhinal Cortex | 1 | 2014 | 272 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2015 | 600 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.030 |
Why?
|
| Microcirculation | 2 | 2008 | 1286 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2013 | 346 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 824 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 2007 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 240 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.030 |
Why?
|
| Chromatin | 1 | 2023 | 2934 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 322 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2014 | 624 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Quality Control | 1 | 2014 | 841 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Telomere | 1 | 2017 | 910 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2727 | 0.020 |
Why?
|
| Reference Standards | 1 | 2014 | 1025 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1730 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2012 | 362 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6756 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 2682 | 0.020 |
Why?
|
| Morbidity | 1 | 2016 | 1769 | 0.020 |
Why?
|
| Head-Down Tilt | 1 | 2010 | 64 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2015 | 878 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1994 | 912 | 0.020 |
Why?
|
| Acoustic Impedance Tests | 1 | 2010 | 109 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 642 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2014 | 691 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 233 | 0.020 |
Why?
|
| Infant | 3 | 2021 | 35136 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 313 | 0.020 |
Why?
|
| Hippocampus | 2 | 2014 | 3675 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 380 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4199 | 0.020 |
Why?
|
| Subdural Space | 1 | 2009 | 32 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1788 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2480 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6895 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 1994 | 1152 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 18111 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 265 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 943 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1580 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 254 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2018 | 3420 | 0.020 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 612 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 2031 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 1005 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 2025 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2010 | 334 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2014 | 2290 | 0.020 |
Why?
|
| Executive Function | 1 | 2016 | 1364 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 767 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 1534 | 0.020 |
Why?
|
| Iceland | 1 | 2007 | 183 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 651 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2008 | 292 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 894 | 0.020 |
Why?
|
| Glycine | 1 | 2010 | 671 | 0.020 |
Why?
|
| Troponin I | 1 | 2011 | 619 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 930 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 1203 | 0.020 |
Why?
|
| Actins | 1 | 1994 | 2121 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6386 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 889 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 6622 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2018 | 12208 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2564 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7279 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 754 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 128 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 1808 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.020 |
Why?
|
| North America | 1 | 2009 | 1249 | 0.020 |
Why?
|
| Half-Life | 1 | 2006 | 661 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7181 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6256 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 996 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7785 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1713 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.020 |
Why?
|
| Self Report | 1 | 2016 | 3558 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 2065 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1423 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2008 | 729 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2010 | 12026 | 0.020 |
Why?
|
| Sweden | 1 | 2007 | 1345 | 0.020 |
Why?
|
| Education | 1 | 2007 | 543 | 0.020 |
Why?
|
| Nafcillin | 1 | 2004 | 25 | 0.020 |
Why?
|
| Mice | 3 | 2018 | 81183 | 0.020 |
Why?
|
| Cytokines | 1 | 2019 | 7322 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2012 | 5179 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 264 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3870 | 0.010 |
Why?
|
| Creatinine | 1 | 2009 | 1919 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 547 | 0.010 |
Why?
|
| Metabolomics | 1 | 2012 | 1484 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 2752 | 0.010 |
Why?
|
| Animals | 4 | 2018 | 168757 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1460 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 2994 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2014 | 2921 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3507 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2006 | 1654 | 0.010 |
Why?
|
| Skull | 1 | 2007 | 813 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2003 | 113 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2212 | 0.010 |
Why?
|
| Poverty | 1 | 2013 | 2660 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 1177 | 0.010 |
Why?
|
| Mitochondria | 1 | 1994 | 3520 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 1917 | 0.010 |
Why?
|
| tau Proteins | 1 | 2010 | 1868 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 534 | 0.010 |
Why?
|
| Vancomycin | 1 | 2004 | 501 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12797 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9648 | 0.010 |
Why?
|
| Medical Records | 1 | 2006 | 1413 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4258 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 41006 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2373 | 0.010 |
Why?
|
| Headache | 1 | 2007 | 1226 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15165 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7301 | 0.010 |
Why?
|
| Smoking | 1 | 2014 | 8987 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 21827 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1790 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2012 | 3309 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 2000 | 643 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6489 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1994 | 182 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2000 | 804 | 0.010 |
Why?
|
| Myosins | 1 | 1994 | 409 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25625 | 0.010 |
Why?
|
| Thrombosis | 1 | 2005 | 2968 | 0.010 |
Why?
|
| Point Mutation | 1 | 1994 | 1623 | 0.010 |
Why?
|
| Protein Binding | 1 | 1994 | 9386 | 0.000 |
Why?
|